Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
3.04 USD | 0.00% | +9.75% | -4.40% |
Mar. 07 | Lumos Pharma, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 07 | Transcript : Lumos Pharma, Inc., 2023 Earnings Call, Mar 07, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.40% | 24.67M | |
+25.42% | 48.09B | |
+47.70% | 40.62B | |
-2.61% | 40.43B | |
-6.20% | 28.36B | |
+7.60% | 24.89B | |
-19.01% | 19.01B | |
+29.22% | 12.09B | |
-0.97% | 11.88B | |
-0.65% | 11.8B |
- Stock Market
- Equities
- LUMO Stock
- News Lumos Pharma, Inc.
- Cantor Fitzgerald Adjusts Lumos Pharma's Price Target to $10 From $14, Keeps Overweight Rating